Saa3 (Serum amyloid A3) showed the most dramatic upregulation (14.33-fold at the mRNA level, with protein levels reaching detection limits in IRI vs. SHAM), indicating its potential as a central inflammatory mediator in stroke pathology. Here, SAA3P is linked to stroke disorder.